Mineralys Therapeutics Inc (MLYS)

Jul 27, 2026

New Mineralys hires receive stock awards vesting over four years - Stock Titan

Jul 27, 2026

Jul 27, 2026

Mineralys Therapeutics Inc (MLYS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Jul 27, 2026

Mineralys Therapeutics Inc (MLYS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 27, 2026

Jul 26, 2026

Mineralys Therapeutics Inc (MLYS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 26, 2026

Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026

Jul 25, 2026

Mineralys Therapeutics Inc (MLYS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 25, 2026

Jul 25, 2026

Mineralys Therapeutics, Inc. Revenue Breakdown – NASDAQ:MLYS - TradingView

Jul 25, 2026

Jul 25, 2026

MLYS|Mineralys Therapeutics Inc|Price:27.920|Chg%:+1.210 - TradingKey

Jul 25, 2026

Jul 25, 2026

MLYS|Mineralys Therapeutics Inc|Price:27.856|Chg%:+1.146 - TradingKey

Jul 25, 2026

Jul 24, 2026

Mineralys Therapeutics Inc (MLYS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 24, 2026

Jul 23, 2026

Mineralys Chief Commercial Officer Eric Warren disposes of $199,900 in common shares - Bitget

Jul 23, 2026

Jul 23, 2026

Form 4 Mineralys Therapeutics Inc For: 23 July By Investing.com - Investing.com Nigeria

Jul 23, 2026

Jul 23, 2026

Mineralys Therapeutics CCO Eric Warren sells $199k in shares - Investing.com

Jul 23, 2026

Jul 23, 2026

Mineralys (NASDAQ: MLYS) CCO sells 7,438 shares after option exercise - Stock Titan

Jul 23, 2026

Jul 21, 2026

Form 4 Mineralys Therapeutics Inc For: 21 July By Investing.com - Investing.com Australia

Jul 21, 2026

Jul 21, 2026

Mineralys Therapeutics (MLYS) affiliate plans 7,438-share stock sale after options exercise - Stock Titan

Jul 21, 2026

Jul 21, 2026

Mineralys Therapeutics CMO David Rodman disposes of $11,036 in shares By Investing.com - Investing.com Nigeria

Jul 21, 2026

Jul 21, 2026

Mineralys Therapeutics CMO David Rodman disposes of $11,036 in shares - Investing.com

Jul 21, 2026

Jul 21, 2026

Mineralys Therapeutics, Inc. (MLYS): Analyst Consensus Points to a Promising 83% Upside Potential - DirectorsTalk Interviews

Jul 21, 2026

Jul 21, 2026

Mineralys CMO David Malcom Rodman disposes of 416 common shares worth $11,036.48 - Bitget

Jul 21, 2026

Jul 19, 2026

Responsive Playbooks and the MLYS Inflection - Stock Traders Daily

Jul 19, 2026

Jul 17, 2026

Form 144 Mineralys Therapeutics For: 17 July By Investing.com - Investing.com Nigeria

Jul 17, 2026

Jul 17, 2026

Mineralys Therapeutics (MLYS) insider schedules 416-share sale after option exercise - Stock Titan

Jul 17, 2026

Jul 16, 2026

Mineralys Executive Stock Sale Analysis - Intellectia AI

Jul 16, 2026

Jul 16, 2026

A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date - The Motley Fool

Jul 16, 2026

Jul 16, 2026

What to Know About This Mineralys Insider Sale Before a December FDA Date - The Motley Fool

Jul 16, 2026

Jul 16, 2026

Mineralys Therapeutics (MLYS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr

Jul 16, 2026

Jul 16, 2026

Mineralys Therapeutics (MLYS) Q3 2025 earnings summary - Quartr

Jul 16, 2026

Jul 16, 2026

Mineralys therapeutics CMO Rodman sells $556,671 in shares By Investing.com - Investing.com South Africa

Jul 16, 2026

Jul 16, 2026

Mineralys therapeutics CMO Rodman sells $556,671 in shares - Investing.com UK

Jul 16, 2026

Jul 16, 2026

Form 4 Mineralys Therapeutics Inc For: 15 July By Investing.com - Investing.com South Africa

Jul 16, 2026

Jul 16, 2026

Mineralys Therapeutics CEO Jon Congleton sells $291,441 in stock By Investing.com - Investing.com South Africa

Jul 16, 2026

Jul 15, 2026

Insider Sell: CEO Jon Congleton Sells 10,700 Shares of Mineralys Therapeutics Inc (MLYS) - GuruFocus

Jul 15, 2026

Jul 15, 2026

Mineralys Therapeutics (MLYS) CMO sells 20,407 shares and exercises options - Stock Titan

Jul 15, 2026

Jul 15, 2026

Mineralys Therapeutics (MLYS) CEO logs 10,700-share sale under Rule 10b5-1 plan - Stock Titan

Jul 15, 2026

Jul 15, 2026

Planned 6,349-share stock sale by Mineralys Therapeutics (NASDAQ: MLYS) - Stock Titan

Jul 15, 2026

Jul 15, 2026

Frontier tech research, news & data - MLQ.ai

Jul 15, 2026

Jul 14, 2026

Planned 14,058-share sale at Mineralys Therapeutics (NASDAQ: MLYS) - Stock Titan

Jul 14, 2026

Jul 13, 2026

Form 144 Mineralys Therapeutics For: 13 July By Investing.com - Investing.com Australia

Jul 13, 2026

Jul 13, 2026

Mineralys Therapeutics (MLYS) insider plans 10,700-share Rule 144 stock sale - Stock Titan

Jul 13, 2026

Jul 13, 2026

Mineralys Therapeutics (MLYS) insider details stock option exercise and sales - Stock Titan

Jul 13, 2026

Jul 12, 2026

Number of shareholders of Mineralys Therapeutics, Inc. – NASDAQ:MLYS - TradingView

Jul 12, 2026

Jul 11, 2026

Mineralys Therapeutics CMO Rodman sells $65,781 in stock By Investing.com - Investing.com India

Jul 11, 2026

Jul 11, 2026

Mineralys Therapeutics CMO Rodman sells $65,781 in stock - Investing.com India

Jul 11, 2026